NNC0650-0013

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC0650-0013, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of a New Medicine (NNC0650-0013) in Healthy Men [Phase 1]